APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Enterprise Solutions

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cell and Gene Therapy Enterprise Solutions Industry Growth and Trends Forecast to 2032

28 December 2025113 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Enterprise Solutions Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Enterprise Solutions Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Enterprise Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Enterprise Solutions Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Enterprise Solutions Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

According to APO Research, the global Cell and Gene Therapy Enterprise Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cell and Gene Therapy Enterprise Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cell and Gene Therapy Enterprise Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell and Gene Therapy Enterprise Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cell and Gene Therapy Enterprise Solutions market include Thermo Fisher Scientific, Miltenyi Biotec, Bruker Spatial Biology, Charles River Laboratories, Sartorius, Revvity, Red Cross Blood Services, Proteintech Group and Promega Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cell and Gene Therapy Enterprise Solutions market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cell and Gene Therapy Enterprise Solutions market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell and Gene Therapy Enterprise Solutions market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell and Gene Therapy Enterprise Solutions.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cell and Gene Therapy Enterprise Solutions market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cell and Gene Therapy Enterprise Solutions Market by Company

Thermo Fisher Scientific

Miltenyi Biotec

Bruker Spatial Biology

Charles River Laboratories

Sartorius

Revvity

Red Cross Blood Services

Proteintech Group

Promega Corporation

BIOMÉRIEUX

QIAGEN

R&D Systems

Abcam

SGS

Azenta US

Vizient Inc

Cell and Gene Therapy Enterprise Solutions Segment by Type

Cell Therapy-Specific Solutions

Gene Therapy-Specific Solutions

Cell and Gene Therapy Enterprise Solutions Segment by Application

Academic/Research Lab

Biotech/Pharma Company

Clinical/Medical Institution

Cell and Gene Therapy Enterprise Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Enterprise Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Enterprise Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Enterprise Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cell and Gene Therapy Enterprise Solutions companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Enterprise Solutions Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cell and Gene Therapy Enterprise Solutions Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cell and Gene Therapy Enterprise Solutions Market Share by Region (2021-2026) Table 4. Global Cell and Gene Therapy Enterprise Solutions Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cell and Gene Therapy Enterprise Solutions Market Share by Region (2027-2032) Table 6. Global Cell and Gene Therapy Enterprise Solutions Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cell and Gene Therapy Enterprise Solutions Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cell and Gene Therapy Enterprise Solutions Market Size Share by Type (2021-2026) Table 9. Global Cell and Gene Therapy Enterprise Solutions Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cell and Gene Therapy Enterprise Solutions Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cell and Gene Therapy Enterprise Solutions Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cell and Gene Therapy Enterprise Solutions Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cell and Gene Therapy Enterprise Solutions Market Size Share by Application (2021-2026) Table 24. Global Cell and Gene Therapy Enterprise Solutions Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cell and Gene Therapy Enterprise Solutions Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cell and Gene Therapy Enterprise Solutions Industry Trends Table 37. Cell and Gene Therapy Enterprise Solutions Industry Drivers Table 38. Cell and Gene Therapy Enterprise Solutions Industry Opportunities and Challenges Table 39. Cell and Gene Therapy Enterprise Solutions Industry Restraints Table 40. Global Cell and Gene Therapy Enterprise Solutions Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cell and Gene Therapy Enterprise Solutions Revenue Market Share by Company (2021-2026) Table 42. Global Cell and Gene Therapy Enterprise Solutions Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cell and Gene Therapy Enterprise Solutions Key Company Headquarters & Area Served Table 44. Global Cell and Gene Therapy Enterprise Solutions Company, Product Type & Application Table 45. Global Cell and Gene Therapy Enterprise Solutions Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cell and Gene Therapy Enterprise Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Thermo Fisher Scientific Company Information Table 49. Thermo Fisher Scientific Business Overview Table 50. Thermo Fisher Scientific Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Thermo Fisher Scientific Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 52. Thermo Fisher Scientific Recent Development Table 53. Miltenyi Biotec Company Information Table 54. Miltenyi Biotec Business Overview Table 55. Miltenyi Biotec Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Miltenyi Biotec Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 57. Miltenyi Biotec Recent Development Table 58. Bruker Spatial Biology Company Information Table 59. Bruker Spatial Biology Business Overview Table 60. Bruker Spatial Biology Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bruker Spatial Biology Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 62. Bruker Spatial Biology Recent Development Table 63. Charles River Laboratories Company Information Table 64. Charles River Laboratories Business Overview Table 65. Charles River Laboratories Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Charles River Laboratories Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 67. Charles River Laboratories Recent Development Table 68. Sartorius Company Information Table 69. Sartorius Business Overview Table 70. Sartorius Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sartorius Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 72. Sartorius Recent Development Table 73. Revvity Company Information Table 74. Revvity Business Overview Table 75. Revvity Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Revvity Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 77. Revvity Recent Development Table 78. Red Cross Blood Services Company Information Table 79. Red Cross Blood Services Business Overview Table 80. Red Cross Blood Services Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Red Cross Blood Services Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 82. Red Cross Blood Services Recent Development Table 83. Proteintech Group Company Information Table 84. Proteintech Group Business Overview Table 85. Proteintech Group Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Proteintech Group Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 87. Proteintech Group Recent Development Table 88. Promega Corporation Company Information Table 89. Promega Corporation Business Overview Table 90. Promega Corporation Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Promega Corporation Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 92. Promega Corporation Recent Development Table 93. BIOMÉRIEUX Company Information Table 94. BIOMÉRIEUX Business Overview Table 95. BIOMÉRIEUX Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. BIOMÉRIEUX Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 97. BIOMÉRIEUX Recent Development Table 98. QIAGEN Company Information Table 99. QIAGEN Business Overview Table 100. QIAGEN Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. QIAGEN Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 102. QIAGEN Recent Development Table 103. R&D Systems Company Information Table 104. R&D Systems Business Overview Table 105. R&D Systems Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. R&D Systems Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 107. R&D Systems Recent Development Table 108. Abcam Company Information Table 109. Abcam Business Overview Table 110. Abcam Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Abcam Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 112. Abcam Recent Development Table 113. SGS Company Information Table 114. SGS Business Overview Table 115. SGS Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. SGS Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 117. SGS Recent Development Table 118. Azenta US Company Information Table 119. Azenta US Business Overview Table 120. Azenta US Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Azenta US Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 122. Azenta US Recent Development Table 123. Vizient Inc Company Information Table 124. Vizient Inc Business Overview Table 125. Vizient Inc Cell and Gene Therapy Enterprise Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Vizient Inc Cell and Gene Therapy Enterprise Solutions Product Portfolio Table 127. Vizient Inc Recent Development Table 128. North America Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2026) Table 131. North America Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Cell and Gene Therapy Enterprise Solutions Market Share Forecast by Country (2027-2032) Table 133. Europe Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2026) Table 136. Europe Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Cell and Gene Therapy Enterprise Solutions Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2026) Table 141. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Share Forecast by Country (2027-2032) Table 143. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2026) Table 146. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Cell and Gene Therapy Enterprise Solutions Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2026) Table 151. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cell and Gene Therapy Enterprise Solutions Product Image Figure 3. Global Cell and Gene Therapy Enterprise Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cell and Gene Therapy Enterprise Solutions Market Size (2021-2032) & (US$ Million) Figure 5. Global Cell and Gene Therapy Enterprise Solutions Market Share by Region: 2025 VS 2032 Figure 6. Global Cell and Gene Therapy Enterprise Solutions Market Share by Region (2021-2032) Figure 7. North America Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cell Therapy-Specific Solutions Image Figure 13. Global Cell Therapy-Specific Solutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Gene Therapy-Specific Solutions Image Figure 15. Global Gene Therapy-Specific Solutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Cell and Gene Therapy Enterprise Solutions Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Cell and Gene Therapy Enterprise Solutions Market Share by Type 2025 VS 2032 Figure 18. North America Cell and Gene Therapy Enterprise Solutions Market Size Share by Type (2021-2032) Figure 19. Europe Cell and Gene Therapy Enterprise Solutions Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Share by Type (2021-2032) Figure 21. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Cell and Gene Therapy Enterprise Solutions Market Size Share by Type (2021-2032) Figure 23. Academic/Research Lab Image Figure 24. Global Academic/Research Lab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Biotech/Pharma Company Image Figure 26. Global Biotech/Pharma Company Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Clinical/Medical Institution Image Figure 28. Global Clinical/Medical Institution Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Cell and Gene Therapy Enterprise Solutions Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cell and Gene Therapy Enterprise Solutions Market Share by Application 2025 VS 2032 Figure 31. North America Cell and Gene Therapy Enterprise Solutions Market Size Share by Application (2021-2032) Figure 32. Europe Cell and Gene Therapy Enterprise Solutions Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Share by Application (2021-2032) Figure 34. Latin America Cell and Gene Therapy Enterprise Solutions Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Cell and Gene Therapy Enterprise Solutions Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Cell and Gene Therapy Enterprise Solutions Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Cell and Gene Therapy Enterprise Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Cell and Gene Therapy Enterprise Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2032) Figure 41. Europe Cell and Gene Therapy Enterprise Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Cell and Gene Therapy Enterprise Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2032) Figure 44. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2032) Figure 47. Latin America Cell and Gene Therapy Enterprise Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Cell and Gene Therapy Enterprise Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2032) Figure 50. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Therapy-Specific Solutions
  • Gene Therapy-Specific Solutions
Applications
  • Academic/Research Lab
  • Biotech/Pharma Company
  • Clinical/Medical Institution
Companies covered
  • Thermo Fisher Scientific
  • Miltenyi Biotec
  • Bruker Spatial Biology
  • Charles River Laboratories
  • Sartorius
  • Revvity
  • Red Cross Blood Services
  • Proteintech Group
  • Promega Corporation
  • BIOMÉRIEUX
  • QIAGEN
  • R&D Systems
  • Abcam
  • SGS
  • Azenta US
  • Vizient Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cell and Gene Therapy Enterprise Solutions Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cell and Gene Therapy Enterprise Solutions Market Size by Region (2021-2032)
  5. 1.4.1 Global Cell and Gene Therapy Enterprise Solutions Market Size by Region (2021-2026)
  6. 1.4.2 Global Cell and Gene Therapy Enterprise Solutions Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cell and Gene Therapy Enterprise Solutions Market Size (2021-2032)
  8. 1.5.1 North America Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (2021-2032)
2 Cell and Gene Therapy Enterprise Solutions Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cell Therapy-Specific Solutions
  3. 2.1.2 Gene Therapy-Specific Solutions
  4. 2.2 Global Cell and Gene Therapy Enterprise Solutions Market Size by Type
  5. 2.2.1 Global Cell and Gene Therapy Enterprise Solutions Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Cell and Gene Therapy Enterprise Solutions Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Cell and Gene Therapy Enterprise Solutions Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Cell and Gene Therapy Enterprise Solutions Market Size by Regions
  9. 2.3.1 North America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Type (2021-2026)
3 Cell and Gene Therapy Enterprise Solutions Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Academic/Research Lab
  3. 3.1.2 Biotech/Pharma Company
  4. 3.1.3 Clinical/Medical Institution
  5. 3.2 Global Cell and Gene Therapy Enterprise Solutions Market Size by Application
  6. 3.2.1 Global Cell and Gene Therapy Enterprise Solutions Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Cell and Gene Therapy Enterprise Solutions Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Cell and Gene Therapy Enterprise Solutions Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Cell and Gene Therapy Enterprise Solutions Market Size by Regions
  10. 3.3.1 North America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Cell and Gene Therapy Enterprise Solutions Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cell and Gene Therapy Enterprise Solutions Industry Trends
  2. 4.2 Cell and Gene Therapy Enterprise Solutions Industry Drivers
  3. 4.3 Cell and Gene Therapy Enterprise Solutions Industry Opportunities and Challenges
  4. 4.4 Cell and Gene Therapy Enterprise Solutions Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cell and Gene Therapy Enterprise Solutions Revenue (2021-2026)
  2. 5.2 Global Cell and Gene Therapy Enterprise Solutions Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cell and Gene Therapy Enterprise Solutions Key Company Headquarters & Area Served
  4. 5.4 Global Cell and Gene Therapy Enterprise Solutions Company, Product Type & Application
  5. 5.5 Global Cell and Gene Therapy Enterprise Solutions Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cell and Gene Therapy Enterprise Solutions Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cell and Gene Therapy Enterprise Solutions Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cell and Gene Therapy Enterprise Solutions Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Cell and Gene Therapy Enterprise Solutions Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Miltenyi Biotec
  8. 6.2.1 Miltenyi Biotec Company Information
  9. 6.2.2 Miltenyi Biotec Business Overview
  10. 6.2.3 Miltenyi Biotec Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Miltenyi Biotec Cell and Gene Therapy Enterprise Solutions Product Portfolio
  12. 6.2.5 Miltenyi Biotec Recent Developments
  13. 6.3 Bruker Spatial Biology
  14. 6.3.1 Bruker Spatial Biology Company Information
  15. 6.3.2 Bruker Spatial Biology Business Overview
  16. 6.3.3 Bruker Spatial Biology Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bruker Spatial Biology Cell and Gene Therapy Enterprise Solutions Product Portfolio
  18. 6.3.5 Bruker Spatial Biology Recent Developments
  19. 6.4 Charles River Laboratories
  20. 6.4.1 Charles River Laboratories Company Information
  21. 6.4.2 Charles River Laboratories Business Overview
  22. 6.4.3 Charles River Laboratories Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Charles River Laboratories Cell and Gene Therapy Enterprise Solutions Product Portfolio
  24. 6.4.5 Charles River Laboratories Recent Developments
  25. 6.5 Sartorius
  26. 6.5.1 Sartorius Company Information
  27. 6.5.2 Sartorius Business Overview
  28. 6.5.3 Sartorius Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sartorius Cell and Gene Therapy Enterprise Solutions Product Portfolio
  30. 6.5.5 Sartorius Recent Developments
  31. 6.6 Revvity
  32. 6.6.1 Revvity Company Information
  33. 6.6.2 Revvity Business Overview
  34. 6.6.3 Revvity Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Revvity Cell and Gene Therapy Enterprise Solutions Product Portfolio
  36. 6.6.5 Revvity Recent Developments
  37. 6.7 Red Cross Blood Services
  38. 6.7.1 Red Cross Blood Services Company Information
  39. 6.7.2 Red Cross Blood Services Business Overview
  40. 6.7.3 Red Cross Blood Services Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Red Cross Blood Services Cell and Gene Therapy Enterprise Solutions Product Portfolio
  42. 6.7.5 Red Cross Blood Services Recent Developments
  43. 6.8 Proteintech Group
  44. 6.8.1 Proteintech Group Company Information
  45. 6.8.2 Proteintech Group Business Overview
  46. 6.8.3 Proteintech Group Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Proteintech Group Cell and Gene Therapy Enterprise Solutions Product Portfolio
  48. 6.8.5 Proteintech Group Recent Developments
  49. 6.9 Promega Corporation
  50. 6.9.1 Promega Corporation Company Information
  51. 6.9.2 Promega Corporation Business Overview
  52. 6.9.3 Promega Corporation Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Promega Corporation Cell and Gene Therapy Enterprise Solutions Product Portfolio
  54. 6.9.5 Promega Corporation Recent Developments
  55. 6.10 BIOMÉRIEUX
  56. 6.10.1 BIOMÉRIEUX Company Information
  57. 6.10.2 BIOMÉRIEUX Business Overview
  58. 6.10.3 BIOMÉRIEUX Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 BIOMÉRIEUX Cell and Gene Therapy Enterprise Solutions Product Portfolio
  60. 6.10.5 BIOMÉRIEUX Recent Developments
  61. 6.11 QIAGEN
  62. 6.11.1 QIAGEN Company Information
  63. 6.11.2 QIAGEN Business Overview
  64. 6.11.3 QIAGEN Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 QIAGEN Cell and Gene Therapy Enterprise Solutions Product Portfolio
  66. 6.11.5 QIAGEN Recent Developments
  67. 6.12 R&D Systems
  68. 6.12.1 R&D Systems Company Information
  69. 6.12.2 R&D Systems Business Overview
  70. 6.12.3 R&D Systems Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 R&D Systems Cell and Gene Therapy Enterprise Solutions Product Portfolio
  72. 6.12.5 R&D Systems Recent Developments
  73. 6.13 Abcam
  74. 6.13.1 Abcam Company Information
  75. 6.13.2 Abcam Business Overview
  76. 6.13.3 Abcam Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Abcam Cell and Gene Therapy Enterprise Solutions Product Portfolio
  78. 6.13.5 Abcam Recent Developments
  79. 6.14 SGS
  80. 6.14.1 SGS Company Information
  81. 6.14.2 SGS Business Overview
  82. 6.14.3 SGS Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 SGS Cell and Gene Therapy Enterprise Solutions Product Portfolio
  84. 6.14.5 SGS Recent Developments
  85. 6.15 Azenta US
  86. 6.15.1 Azenta US Company Information
  87. 6.15.2 Azenta US Business Overview
  88. 6.15.3 Azenta US Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Azenta US Cell and Gene Therapy Enterprise Solutions Product Portfolio
  90. 6.15.5 Azenta US Recent Developments
  91. 6.16 Vizient Inc
  92. 6.16.1 Vizient Inc Company Information
  93. 6.16.2 Vizient Inc Business Overview
  94. 6.16.3 Vizient Inc Cell and Gene Therapy Enterprise Solutions Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Vizient Inc Cell and Gene Therapy Enterprise Solutions Product Portfolio
  96. 6.16.5 Vizient Inc Recent Developments
7 North America
  1. 7.1 North America Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026)
  3. 7.3 North America Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026)
  3. 8.3 Europe Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026)
  3. 10.3 South America Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cell and Gene Therapy Enterprise Solutions Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst